Processa Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2014 to Q3 2024.
  • Processa Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -195 %, a 23.8% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2023 was -141 %, a 12.3% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2022 was -161 %, a 300% decline from 2021.
  • Processa Pharmaceuticals, Inc. annual Return On Equity for 2021 was -40.4 %, a 70.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -195 +60.9 +23.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -151 +82.2 +35.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -130 +75.3 +36.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -141 +19.8 +12.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -256 -174 -213% Jul 1, 2023 Sep 30, 2023
Q2 2023 -233 -173 -284% Apr 1, 2023 Jun 30, 2023
Q1 2023 -205 -158 -330% Jan 1, 2023 Mar 31, 2023
Q4 2022 -161 -121 -300% Oct 1, 2022 Dec 31, 2022
Q3 2022 -81.8 -16.9 -25.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -60.7 +20.5 +25.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -47.8 +46.5 +49.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.4 +96 +70.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -65 +14.8 +18.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -81.1 -38.6 -90.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -94.2 -51.3 -119% Jan 1, 2021 Mar 31, 2021
Q4 2020 -136 -97.2 -248% Oct 1, 2020 Dec 31, 2020
Q3 2020 -79.7 -44.2 -125% Jul 1, 2020 Sep 30, 2020
Q2 2020 -42.6 -8.91 -26.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -43 -9.3 -27.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -39.2 -0.33 -0.85% Oct 1, 2019 Dec 31, 2019
Q3 2019 -35.5 +16 +31% Jul 1, 2019 Sep 30, 2019
Q2 2019 -33.6 +43.5 +56.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -33.7 +179 +84.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -38.8 -201 -124% Oct 1, 2018 Dec 31, 2018
Q3 2018 -51.5 -132 -164% Jul 1, 2018 Sep 30, 2018
Q2 2018 -77.1 -144 -216% Apr 1, 2018 Jun 30, 2018
Q1 2018 -212 -294 -359% Jan 1, 2018 Mar 31, 2018
Q4 2017 162 +74.7 +85.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 80.6 -42.9 -34.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 66.6 -34.5 -34.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 81.9 -151 -64.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 87.1 -491 -84.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 124 -1.64K -93% Jul 1, 2016 Sep 30, 2016
Q2 2016 101 +4.36K Apr 1, 2016 Jun 30, 2016
Q1 2016 233 +866 Jan 1, 2016 Mar 31, 2016
Q4 2015 578 +1.24K Oct 1, 2015 Dec 31, 2015
Q3 2015 1.76K +2.23K Jul 1, 2015 Sep 30, 2015
Q2 2015 -4.26K -3.99K -1530% Apr 1, 2015 Jun 30, 2015
Q1 2015 -634 -397 -168% Jan 1, 2015 Mar 31, 2015
Q4 2014 -660 Oct 1, 2014 Dec 31, 2014
Q3 2014 -473 Jul 1, 2014 Sep 30, 2014
Q2 2014 -261 Apr 1, 2014 Jun 30, 2014
Q1 2014 -236 Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.